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Abstract
Background and Aims: Roux-en-Y gastric bypass (RYGB) leads to a rapid remission of type 2 diabetes mellitus (T2DM), but
the underlying mode of action remains incompletely understood. L-cell derived gut hormones such as glucagon-like
peptide-1 (GLP-1) and peptide YY (PYY) are thought to play a central role in the anti-diabetic effects of RYGB; therefore, an
improved understanding of intestinal endocrine L-cell adaptability is considered pivotal.
Methods: The full rostrocaudal extension of the gut was analyzed in rats after RYGB and in sham-operated controls ad
libitum fed or food restricted to match the body weight of RYGB rats. Total number of L-cells, as well as regional numbers,
densities and mucosa volumes were quantified using stereological methods. Preproglucagon and PYY mRNA transcripts
were quantified by qPCR to reflect the total and relative hormone production capacity of the L-cells.
Results: RYGB surgery induced hypertrophy of the gut mucosa in the food exposed regions of the small intestine coupled
with a doubling in the total number of L-cells. No changes in L-cell density were observed in any region regardless of
surgery or food restriction. The total gene expression capacity of the entire gut revealed a near 200% increase in both PYY
and preproglucagon mRNA levels in RYGB rats associated with both increased L-cell number as well as region-specific
increased transcription per cell.
Conclusions: Collectively, these findings indicate that RYGB in rats is associated with gut hypertrophy, an increase in L-cell
number, but not density, and increased PYY and preproglucagon gene expression. This could explain the enhanced gut
hormone dynamics seen after RYGB.
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Introduction
The prevalence of severe obesity is rapidly increasing and has
reached epidemic proportions [1]. It is associated with significant
co-morbidities including type 2 diabetes mellitus (T2DM),
hyperlipidemia, arterial hypertension, coronary artery disease,
and liver dysfunction [2]. Bariatric surgery, and in particular
Roux-en-Y gastric bypass (RYGB), is currently the most widely
used intervention method to achieve sustained weight loss in
morbidly obese subjects resulting in a substantial improvement in
co-morbidities and cardiovascular outcome [3,4]. A remarkable
feature of RYGB is the immediate improvement of T2DM even
before significant body weight loss occurs [5,6,7,8]. Thus, body
weight loss per se cannot explain the marked anti-diabetic effect
following RYGB. Although the exact mechanisms underlying the
profound anti-diabetic effects of RYGB remain to be determined,
it is generally assumed that gut hormones such as glucagon-like-
peptide 1 (GLP-1) and peptide YY (PYY) play an important role
[9,10]. Both hormones are produced and secreted primarily in the
intestinal tract by endocrine L-cells and previous studies have
consistently shown increased plasma levels of GLP-1 and PYY
following RYGB, lending support for the involvement of these
hormones in the immediate metabolic response to RYGB [11,12].
In an attempt to separate the effect of a substantial weight loss
from the direct effect of surgery, Laferre`re et al showed that
RYGB surgery increased the ‘‘incretin effect’’ in humans about 5-
fold compared to unoperated body-weight matched controls [13].
Data also suggest that the early increase in insulin release after
RYGB is mediated by other mechanisms than just body weight
loss [14].
RYGB surgery involves a significant rearrangement of the small
intestine, but the post-operative effect on intestinal morphology is
not fully understood. Several types of intestinal-surgery can lead to
profound hormonal and morphological changes. Accordingly, it
has long been recognized that gut resection or inflammation can
lead to both morphological and hormonal changes in the gut
[15,16]. Intestinal resection is associated with increased circulating
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levels of enteroglucagon and glicentin in rats [17,18]. In
agreement, also ileal, but not colonic, resection in humans leads
to increase in enteroglucagon [15]. Furthermore, epithelial
proliferation has been also observed in both rats [19] and humans
[20] after biliopancreatic bypass surgery, a type of bariatric
surgery in which parts of the small bowel are bypassed.
A few studies have examined the density of endocrine cells after
various types of bariatric surgery. Jejunoileal bypass surgery in
obese humans has been coupled to a selective increase in the
density of CCK and somatostatin cells in the duodenum [21]. In
addition, Mumphrey and coworkers [22] recently demonstrated
an increased thickness of the gut mucosa coupled with unchanged
density of CCK, serotonin and GLP-1 positive cell profiles
following RYGB in diet induced obesity (DIO) rats, thus providing
an indirect evidence for an adaptive increase in the number of
endocrine cells. Significant mucosal hypertrophy of the small
bowel after bariatric surgery in rats has previously been
demonstrated by Bueter et al [23]. Furthermore, intestinal
hypertrophy has also been found after biliopancreatic diversion
in rats [24]. Such morphological and cellular alterations may be
linked to changes in the number and function of enteroendocrine
cells leading to increased plasma hormone levels after RYGB.
Hence, improved understanding of the morphological changes
following bariatric surgery is considered important to understand
and possibly further improve these types of surgery.
To test the hypothesis that an altered gut hormonal profile after
RYGB is associated with an increased enteroendocrine cell
number, we used our established RYGB rat model [23,25,26]
and unbiased stereological methods to in-depths investigate the
quantitative morphological changes in the gut after RYGB, as well
as alterations in the number and distribution of endocrine L-cells
in the intestine.
Materials and Methods
Animals
Fifteen male normoglycemic Wistar rats (Harlan Laboratories
Inc., Blackthorn, UK; Elevage Janvier, Le-Genest-St. Isle, France)
weighing 43267.1 g were individually housed under a 12 h/12 h
light-dark cycle at a room temperature of 2162uC. Water and
standard chow was available ad libitum, unless otherwise stated.
Animal experiments were performed at the University of Zu¨rich
and were approved by the Veterinary Office of the Canton Zurich,
Switzerland.
Rats were given one week of acclimatization before being
assigned to RYGB (n= 5) or sham-operation (n= 10). After
surgery, rats received liquid diet for 3 days before access to
normal chow was reintroduced. The sham-operated group was
then randomly divided into two groups. One was fed ad libitum
(SHAM), the other was food restricted to maintain body weight
similar to the RYGB rats (SHAM WM). Food intake was
measured manually at least twice per week throughout the
duration of the study. Based on experiences from previous studies
[23], SHAMWM rats were given approximately 15 g of chow diet
daily, which was offered at dark onset and readjusted every third
day depending on the body weight development of the SHAM
WM compared to the RYGB rats.
Surgery
Surgery was performed according to an established protocol as
previously described [27]. Briefly, rats were food deprived
overnight while water was available ad libitum. Prior to surgery,
rats were weighed, and then anesthetized with isofluorane (4% for
induction, 3% for maintenance). Preoperatively, 0.4 ml/kg
Enrofloxacin and 1 mg/kg Flunixin were administered intraper-
itoneally (ip) as prophylaxis for postoperative infection and pain
relief, respectively. In the sham-operated group, a 7 mm
gastrotomy on the anterior wall of the stomach and a 7 mm
jejunotomy were performed with subsequent closure. In the
RYGB group, the proximal jejunum was divided 15 cm distal to
the pylorus to create a biliopancreatic channel. After identification
of the caecum, the ileum was then followed proximally to create a
common channel of 25 cm. Here, a 7 mm side-to-side jejuno-
jejunostomy between the biliopancreatic channel and the common
channel was performed (Figure 1 A–B).
Sampling, Embedding and Sectioning
The entire small bowel including duodenum and complete
colon was sampled on the day of study termination (23 weeks after
surgery) to ensure similar categorization of the respective
segments. The biliopancreatic channel, the alimentary channel,
the common channel as well as the complete colon were carefully
separated in RYGB operated rats and frozen rapidly on dry ice.
Corresponding segments of jejunum, duodenum, and ileum of
sham-operated rats were identified and separated by the same
surgeon who performed the surgery. Each of the four regions was
subsequently sampled into two sets of transverse biopsies (,4 mm
of length) while still frozen (Figure 1 C). The sampling of biopsies
was carried out using systematic uniform random sampling
principles ensuring an unbiased representation of the entire region
(7–9 samples in total) in each sample set [28]. One set was kept
frozen and processed for RNA gene expression analysis. The other
set of samples was transferred directly to 4% formalin for 10 days,
embedded in two blocks of paraffin (4–5 biopsies per block), and
subsequently cut into 5 mm sections on a Microm HM340E
(ThermoScientific) (Figure 1 C).
Immunostaining
Series of 5 mm adjacent sections were stained for GLP-2
immunoreactivity as a marker for L-cells. The current antibody
has previously been shown to co-localize 100% with GLP-1 in
brainstem preproglucagon expressing neurons [29]. In brief,
sections were deparaffinized in toluene and rehydrated in series
of ethanol. Sections were subjected to antigen retrieval in citrate
buffer, blocked for endogenous peroxidase activity and non-
specific binding before being incubated with primary mouse anti-
GLP-2 antibody (1:16000, GLP2-12F21-A7, kindly provided by
Jes Thorn Clausen, Novo Nordisk A/S) for 1 hour. Sections were
visualized using Envision (DAKO K4007) and finally developed
using diaminobenzidine as a chromagen. Slides were counter-
stained in hematoxylin before they were dehydrated and cover-
slipped with Pertex (Sakura, Denmark).
Stereological Quantification of Volume
Stereological volume estimations were performed using new-
CAST software (Visiopharm, Copenhagen, Denmark) on digital
slides scanned with a 206 objective on an Aperio Scanscope AT
slidescanner (Aperio, California, USA). Images for counting were
sampled in a random systematic way by use of the newCAST
software. Total gut volume and cellular layer volumes were
estimated by point counting using a grid system where all points
hitting the structure of interest were counted. The volume of the
different cell layers was estimated using a 16-point grid at
approximately 6506 magnification designed to ensure the most
efficient precision [30]. The serosa layer was included as a part of
the muscular layer. Tissue processing for paraffin embedding leads
to substantial shrinkage in the tissue. In order to compensate for
shrinkage we corrected the volume data by a shrinkage coefficient.
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This shrinkage coefficient was based on estimations of in-section
shrinkage (i.e. in the XY axis) and length. The XY shrinkage
induced by dehydration and paraffin embedding was estimated by
comparing point counts performed on frozen unshrunken sections
with paraffin embedded sections. The length shrinkage was
estimated by subjecting 2 cm long agarose embedded segments
to dehydration before re-measuring the length.
Stereological Quantification of Cells
The total number of GLP-2 immunoreactive L-cells was
estimated using the principle of the physical disector [31,32,33].
This method relies upon the principle that if a particle is seen in
one section and not the previous, it is counted. For this purpose
tissue sections were sampled as two consecutive sections, thus
obtaining two overlapping adjacent sections on one slide. The
slides were stained for GLP-2 immunoreactivity (-ir) as described
above, scanned and digitized using a Aperio Scanscope AT
slidescanner with a 206 objective and finally analyzed on a
computer running CAST software package.
qPCR
Frozen biopsies were placed in tubes with TRIzol reagent
(Invitrogen 15596-026) and lysing matrix. Samples were homog-
enized using a FastPrep-24 and total RNA was purified according
to manufactures specifications. RNA total content and quality was
determined by absorbance (NanoDrop Technologies). cDNA was
synthesized from 2 mg of RNA using SuperScriptH II (Invitrogen
18064-022) reverse transcriptase according to manufacturers
specifications. cDNA was diluted 30-fold. QPCR was performed
using SYBR green (Stratagene 600828). Total reaction volume
was 25 ml per reaction. 18s was used as an internal standard. The
following primer sequences were used: PYY: TGCTCTTCACA-
GACGACAGC and CATGCAAGTGAAGTCGGTGT, prepro-
glucagon: CTCTGGTGGCAAGGTTATCG and CATTCA-
CAGGGCACATTCAC, 18S:
TGTCAATCCTGTCCGTGTCC and ACGGACCAGAGC-
GAAAGCAT. Total expression levels were calculated as relative
expression multiplied by total mucosa volume. The mean
expression per cell was calculated by dividing total expression
with total number of cells.
Stereological Error and Statistics
The precision of the estimator was evaluated in comparison to
the biological variability in a previous study. In this study the
mean regional coefficient of error (CE) was calculated was found
to be 0.07 [34]. All stereological estimates were based on 9–12
sections per region with a mean number of 428 counting events
for the volumetric quantification, and 122 counting events per
region for number estimation providing a coefficient or error
Figure 1. RYGB surgery and sampling procedure. The RYGB surgical procedures connecting the upper jejunum (alimentary channel, red) to the
gastric pouch circumpassing the duodenum (biliopancreatic channel, green) (A–B). At termination each segment was sampled using stereological
sampling principles into two sets of 7–9 transverse biopsies. One set was used for histology, one set for qPCR analyses (C).
doi:10.1371/journal.pone.0065696.g001
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below 0.10 [28]. The shape factor for the physical dissector was
estimated to 25.
Data are presented as mean 6 SEM. Statistical significance
between groups was determined by one-way ANOVA followed by
Tukey’s post-hoc analysis, or two-way ANOVA followed by
Bonferroni post-hoc analysis. P-value below 0.05 was considered
statistically significant.
Results
Body Weight and Food Intake
After a short initial period of postoperative weight loss, SHAM
rats returned to normal weight gain for the remainder of the study.
At the day of termination, the body weight in the SHAM group
was significantly higher than in the RYGB group (SHAM
617610.8 and RYGB 395619.2; p,0.001) (Figure 2). There
was no significant difference in body weight between the RYGB
and the SHAM WM on the day of termination (SHAM WM
426612.6 g, p= 0.339) (Figure 2). The SHAM and RYGB group
had an average spontaneous daily food intake of approximately 26
and 24 grams per day, respectively (p,0.001) (Figure 2), while
the WM group received approx. 15 grams of chow per day.
Gut Morphometry
The length of the alimentary channel was increased by nearly
20% in the RYGB group compared to SHAM, and decreased by
10% in the SHAM WM group (Table 1). In contrast, the length
of the biliopancreatic channel, common channel and colon
appeared to be unaffected by surgery or food restriction
(Table 1). A qualitative assessment of gut morphology in cross
sections revealed a noticeable hypertrophy of the gut in RYGB
operated rats compared to SHAM and SHAMWM groups. These
changes were most noticeable in the alimentary channel as a
thickening of the mucosa layer with elongated villi and deeper
epithelial crypts (Figure 3 A–C). The stereological assessment of
total gut mucosa volume demonstrated an increase of more than
100% in the RYGB group compared to SHAM (p,0.001)
(Figure 4 A). The marked mucosal hypertrophy in RYGB
animals was observed in all food exposed gut regions (alimentary
channel, common channel and colon) but not the bypassed
biliopancreatic limb (Figure 4 B). The greatest increase in RYGB
mucosa volume was observed in the alimentary channel (150%,
p,0.001), followed by the common channel (140%, p,0.01) and
colon, though the latter did not reach statistical significance (50%,
p.0.05) (Figure 4 B). In WM animals, the biliopancreatic and
alimentary channel tended to have a slightly reduced mucosa
volume compared to SHAM (Figure 4 B).
Total and Regional Number of L-cells
L-cells were clearly identified by GLP-2 immunohistochemistry
(Figure 3 D–E). Similar to mucosal volume, the stereological
quantification of L-cell numbers revealed a doubling in the total
number of L-cells in the RYGB animals compared to SHAM
(7.960.6 mill vs. 17.561.5 mill. p,0.001) (Figure 4 C). The
greatest increase in L-cell number was confined to the alimentary
channel (170%, p,0.001) followed by the common channel
(130%, p,0.05) and the colon, though the latter did not reach
statistical significance (40%, p.0.05). No change was observed in
the biliopancreatic limb. In general, the WM control group
displayed no changes in total or regional L-cell number as
compared to the sham group (Figure 4 D).
Total and regional L-cell density remained unchanged among
groups (Figure 3 D–F, Figure 4 E). In general, the L-cell
density was lowest in the duodenal region with increasing density
along the proximal-distal axis (Figure 4 F). L-cell density was
highest in the distal jejuno-ileum (common channel) and was
slightly lower in the colon.
Preproglucagon and PYY Gene Expression
qPCR analysis of preproglucagon and peptide YY expression in
the eight different gut segments was used to examine the relative
mRNA levels along the rostro-caudal axis of the gut. This analysis
Figure 2. Body weight change for gastric bypass (n=5) and sham-operated rats ad libitum fed (n=5) and sham-operated body
weight matched (n=5) (A). Average daily food intake over 20 weeks for sham operated ad libitum fed rats and for gastric bypass rats (B).
doi:10.1371/journal.pone.0065696.g002
Table 1. Length of gut segments.
SHAM WM RYGB
Biliopancreatic channel 19.961.2 19.961.0 19.060.50
Alimentary channel 71.362.6 63.963.1* 85.664.8*
Common channel 21.361.1 23.160.9 21.460.42
Colon 17.860.73 16.960.72 19.460.65
Total 130.364.2 115.869.2 145.465.6
All values are presented as mean 6 SEM. Significant differences were observed.
Statistical analysis: One-way ANOVA with Tukey’s Multiple Comparison post-hoc
test, (* = p,0.05, for significance).
doi:10.1371/journal.pone.0065696.t001
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revealed a nonsignificant tendency towards increased gene
expression in the common channel at the level of confluence of
food, gastric juices, bile and pancreatic enzymes (Figure 5 A–B).
When comparing the mean regional expression per cell (total
preproglucagon expression/number of cells) gene expression in the
common channel in the RYGB group was more than 4 times
higher than the corresponding region in the SHAM animals (data
not shown). In order to get an estimate of the total preproglucagon
and PYY mRNA levels in the different gut regions, we
incorporated regional volume changes into the calculation
(Figure 4 C–D). When mucosal volume was taken into consid-
eration, this revealed a rise, which however was not significant, in
total preproglucagon and PYY gene expression in both the
alimentary channel and the common channel (Figure 5 C–D). As
seen in Figure 4E and 4F, total PYY (p,0.01) and preproglucagon
(p,0.05) mRNA expression was significantly two-fold increased in
the RYGB compared to the SHAM group (Figure 5 E–F). In
contrast, no changes were observed in the SHAM WM animals
(p.0.05).
Discussion
The present study provides the first stereological report of
morphological changes in the rat gut after RYGB surgery. We
show that this particular type of bariatric surgery results in a more
than doubling of total mucosa volume in the small intestine with
concomitant increases in the absolute number of L-cells, without
affecting L-cell density. The observation that the alimentary region
contains by far the highest number of L-cells in both the normal
and gastric bypass operated gut is in contrast to the general view
that L-cells are confined to the ileum and colon [35,36]. Finally,
we demonstrate that following RYGB both preproglucagon and
PYY mRNAs are upregulated in the L-cells located in the
common channel where food is mixed with bile acids, gastric and
pancreatic secretions and enzymes.
A number of preclinical and clinical studies have indicated that
bariatric surgery leads to structural changes in gut morphometry
[20,37,38,39,40]. Using conventional quantitative methods, villus
lengths, crypt depth and crypt proliferation have been reported to
be increased in nutrient-stimulated regions in rat models of RYGB
[22,23,37,38], biliopancreatic diversion [20,39] and ileal transpo-
sition [40]. Similarly, increased villus height and gut length have
been reported in humans following jejuno-ileal bypass surgery
[41,42,43]. The present rat study is in close agreement with the
finding that RYGB in human individuals leads to substantial and
regional selective hypertrophy of the gut. Notably, we demonstrate
by the use of stereological methods, that RYGB leads to L-cell
hyperplasia. The remarkable increase in the number of L-cells by
a factor of about 2.5 (7.960.6 mill vs. 17.561.5 mill. p,0.001)
underscores the marked plasticity of the gut in response to surgical
interventions that alter nutrient flow. In contrast, no changes were
observed in L-cell density. Therefore, it appears that L-cell
densities are genetically encoded in the general mucosa turnover,
and that L-cell hyperplasia is secondary adaptive mechanism to
the marked changes in gut volume. A similar mechanism has also
recently been suggested by Mumphrey and coworkers [22]. The
increase in L-cell number reported in the present study does not
account for the elevated postprandial GLP-1 and PYY plasma
levels observed after RYGB in rodents and humans alone [44]. In
this respect it should be noted that the mRNA transcriptional
Figure 3. Representative micrographs of gut morphology (A–C) and GLP-2 immunohistochemistry (D–F) in the alimentary channel
of SHAM, RYGB and SHAM WM animals.
doi:10.1371/journal.pone.0065696.g003
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Figure 4. Stereological estimates of total and regional gut volume (A–B), L-cell number (C–D) and L-cell density (E–F). All values are
presented as mean 6 SEM. One-way ANOVA with Tukey’s Multiple Comparison post-hoc test, (* = p,0.05,** = p,0.01, *** = p,0.001 for
significance).
doi:10.1371/journal.pone.0065696.g004
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activity of the L-cells was increased in the common channel after
RYGB hereby representing an additional potential mechanism
leading to increased release of GLP-1 and PYY.
The reported increase in L-cell density along the rostro-caudal
axis of the small intestine and the colon is in line with many
previous reports [35,36]. However, the present study present novel
data on the absolute endocrine cell numbers in each region. These
Figure 5. Regional preproglucagon (A) and PYY (B) gene expression normalized to 18s and corrected for the varying epithelial
volume (C–D). Total preproglucagon (E) and PYY (F) gene expression. All values are arbitrary units presented as mean 6 SEM. Statistical analysis:
One-way ANOVA with Tukey’s Multiple Comparison post-hoc test, SHAM vs. RYGB (*); VW vs. RYGB (ˆ). (*ˆ = p,0.05,**ˆˆ = p,0.01, for significance).
doi:10.1371/journal.pone.0065696.g005
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measurements incorporate the size and the length of each
respective region and point to the alimentary channel as the main
L-cell contributor after RYGB. Hence, total L-cell numbers in the
alimentary limb are higher than the more distal gut regions despite
the lower L-cell density. These data indicate that the main part of
the L-cell population is actually found proximal to the traditionally
defined ileum - in contrast to the generally held view [45] – but in
line with other recent data from our laboratory [34]. However, it
should be recognized that the distribution between RYGB regions
may vary depending on the surgically defined length of each gut
segment.
The nature of the signals leading to intestinal hypertrophy
remains to be identified. It is tempting to speculate that
mechanical or nutrient induced stimuli caused by the introduction
of undigested food particles in the upper jejunum are involved; this
would also explain the lack of hypertrophy in the nutrient diverted
biliopancreatic limb observed in this study and by others [22].
Increased villus length and increased cell number have been
demonstrated in mice fed a high-fat diet for 8 weeks [46].
Moreover, hypertrophy has also been described from a number of
small bowel resection studies [47,48] where the remaining small
intestine increases in wall thickness, villus height and total weight.
This adaptation compensates to some extent for the lost nutrient
absorption capacity in the resected small bowel.
It is remarkable that hormonal changes are triggered with
simultaneous improvement in glucose homeostasis prior to
significant weight loss following RYGB [49]. Increased GLP-1
secretion is considered the primary contributor in mediating the
rapid improvements in glycemic control [50,51]. Hence, to
elucidate a possible mechanism linked to the highly elevated levels
of circulating GLP-1 and PYY in our RYGB rat model [11,52], we
investigated not only changes in the absolute number of L-cells
following RYGB but also preproglucagon and PYY expression in
each intestinal segment. Whereas the alimentary and common
channel contributed equally to changes in total preproglucagon
and PYY expression, increased mRNA expression per cell was
only seen in the common channel where the biliopancreatic
channel is fused with the alimentary channel. In this region,
macronutrients are mixed with bile acids, gastric and pancreatic
juices, suggesting that these digestive components directly stimu-
late L-cell gene expression in this region. Accordingly, bile acids
have previously been shown to increase L-cell secretion [53,54,55]
through the bile specific G-protein coupled receptor TGR5 [53].
This receptor is involved in a range of beneficial metabolic effects
including weight gain resistance, and maintenance of glucose
homeostasis and insulin sensitivity [56].
A secondary effect of increased L-cell stimulation is secretion of
GLP-2. GLP-2, a prominent mediator of epithelial proliferation
[57] synthesized and secreted from the L-cell in a 1:1 stoichio-
metric ratio with GLP-1 [58,59], may also play a central role in
the mucosal hypertrophy. In this respect it should be noted that
elevated GLP-2 plasma measurements previously has been
documented in this specific RYGB model [26]. Another possible
mechanism stimulating both intestinal hypertrophy and L-cell
secretion are changes in gut microbiota [60]. More studies are
however needed to evaluate the exact mechanism leading to
changes in gut microbiota following RYGB surgery, and to
elucidate the direct or indirect effects of these changes on the
endocrine cells.
All endocrine cells are believed to originate from the same
precursor cells [61]. Consequently, it is plausible that other gut
enteroendocrine, e.g. GIP-, neurotensin and CCK cells, are
affected by the gut hypertrophy following RYGB. As most of the
endocrine cell types in the intestine produce hormones with
anorectic effects, and many hormones are elevated in postprandial
plasma after surgery, gut hypertrophy may have important
implications for unraveling the anti-diabetes/anti-obesity effect
of RYGB surgery [62,63]. Additional studies focusing on other
endocrine markers are warranted to substantiate this hypothesis.
Our findings in this report are subject to some limitations. First,
our data apply to rats and the effects observed on intestinal
hypertrophy and L-cell numbers seen in this study have not yet
been reported in humans. However, comparable changes in
plasma hormone levels in humans and rats after RYGB imply that
similar changes in the human endocrine cell populations may also
occur. Secondly, the rats used were not obese or on a high-fat diet.
Even though sham animals gained more than 200 grams over the
other groups and were significantly heavier than the other groups
at the time of study termination, we cannot exclude that our
findings would have differed slightly had our rats been fed a high
fat diet. Thirdly, the current study did not examine hormonal
plasma levels. Although these have previously been measured and
although changes after RYGB are very consistent across published
studies, we cannot make a direct link between our findings of
increased L-cell numbers in the gut and plasma concentrations of
the respective hormones in the present study. Hence, we cannot
directly correlate the L-cell mass or mRNA transcripts to
circulating PYY and GLP-1 levels. Finally, it should be noted
that we used non-diabetic chow fed rats in our study. Hence, the
effect observed on L-cell expression and L-cell hyperplasia cannot
be directly coupled to glycemic improvements in obese T2DM
patients undergoing RYGB.
In conclusion, RYGB in rats is associated with gut hypertrophy,
an increase in L-cell number and increased preproglucagon and
PYY gene expression. The data suggest that elevated GLP-1 and
PYY hormone levels after RYGB surgery are a consequence of L-
cell proliferation secondary to gut hypertrophy and hereby provide
further insight into the possible mechanisms underlying the
marked remission of T2DM following RYGB.
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